CN Patent

CN101094679A — 包含taurinamide衍生物和生物学可接受的盐和酸并加入低浓度的肝素的抗微生物封闭溶液

Assigned to ND Partners LLC · Expires 2007-12-26 · 18y expired

What this patent protects

本发明涉及在将血液导管插入患者中后抑制或预防感染并保护其免于开放并发症，其包括向该器件给药药学有效量的包含下述成分的组合物：(A)至少一种taurinamide衍生物，(B)至少一种选自生物学可接受的酸及其生物学可接受的盐的化合物，和(C)低浓度的肝素。

USPTO Abstract

本发明涉及在将血液导管插入患者中后抑制或预防感染并保护其免于开放并发症，其包括向该器件给药药学有效量的包含下述成分的组合物：(A)至少一种taurinamide衍生物，(B)至少一种选自生物学可接受的酸及其生物学可接受的盐的化合物，和(C)低浓度的肝素。

Drugs covered by this patent

Patent Metadata

Patent number
CN101094679A
Jurisdiction
CN
Classification
—
Expires
2007-12-26
Drug substance claim
No
Drug product claim
No
Assignee
ND Partners LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.